0 Comentários
0 Compartilhamentos
530 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça o login para curtir, compartilhar e comentar!
-
Clinical Oncology Next Generation Sequencing Market Size, Share & Growth Analysis | Precision Cancer Diagnostics Trends and Forecast 2026–2033"According to the latest report published by Data Bridge Market Research, the Clinical Oncology Next Generation Sequencing Market Data Bridge Market Research analyses that the clinical oncology next generation sequencing market which was USD 592.56 million in 2021, would rocket up to USD 1825.30 million by 2029, and is expected to undergo a CAGR of 15.1% during the forecast period...0 Comentários 0 Compartilhamentos 497 Visualizações 0 Anterior
-
DNA Damage Response (DDR) Targeted Therapy Market Size Expected to Grow Significantly During 2026–2032 Driven by Rising Demand for Precision Oncology Treatments"DNA Damage Response (DDR) Targeted Therapy Market Summary: According to the latest report published by Data Bridge Market Research, the DNA Damage Response (DDR) Targeted Therapy Market The global DNA Damage Response (DDR) targeted therapy market size was valued at USD 3.02 billion in 2025 and is expected to reach USD 10.75 billion by 2033, at a CAGR of 17.20% during the forecast...0 Comentários 0 Compartilhamentos 83 Visualizações 0 Anterior
-
Global Head and Neck Cancer Market to Reach US$ 2.9 Billion by 2031 as Immunotherapy and Precision Oncology Drive Industry GrowthThe global industry was valued at US$ 1.6 Bn in 2022 and is estimated to grow at a CAGR of 6.8% from 2023 to 2031, reaching US$ 2.9 Bn by the end of 2031. The head and neck cancer market is witnessing significant growth due to the rising prevalence of cancer cases, increasing awareness regarding early diagnosis, and advancements in targeted therapies and immunotherapy treatments. Head and neck...0 Comentários 0 Compartilhamentos 191 Visualizações 0 Anterior
-
Hadron Therapy Market Set for Significant Growth as Precision Oncology Gains MomentumThe global Hadron Therapy Market is witnessing remarkable growth as healthcare systems increasingly adopt advanced radiation oncology technologies designed to improve cancer treatment outcomes. Hadron therapy, which includes proton therapy and carbon ion therapy, has emerged as one of the most promising innovations in modern oncology. By delivering highly precise radiation doses directly to...0 Comentários 0 Compartilhamentos 130 Visualizações 0 Anterior
-
Hemato Oncology Testing Market Size, Precision Medicine Trends, and Strategic Industry Outlook 2032"Latest Insights on Executive Summary Hemato Oncology Testing Market Share and Size During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 7.80% , primarily driven by the rising incidence of blood cancers This Hemato Oncology Testing Market research report proves to be true in serving the purpose of businesses of making enhanced decisions,...0 Comentários 0 Compartilhamentos 827 Visualizações 0 Anterior
-
Hereditary Cancer Testing Market Size and Precision Oncology Trends 2033The growing emphasis on personalized medicine and proactive risk management is driving a significant expansion in genomic screening. The Hereditary Cancer Testing Market was valued at USD 7.04 billion in 2024 and is projected to reach USD 18.85 billion by 2032, growing at a CAGR of 20.87% during the forecast period of 2025 to 2032. This growth is fueled by the...0 Comentários 0 Compartilhamentos 468 Visualizações 0 Anterior
-
Intravenous Infusion Pump Market: How Is the Chemotherapy Boom Driving Precision Oncology Delivery?The intravenous infusion pump market — the oncology-critical sector where therapeutic index narrowness demands absolute dosing accuracy — represents the cancer care precision frontier, with the Intravenous Infusion Pump Market reflecting chemotherapy-specific pumps as the fastest-growing disease indication segment. Biologic and biosimilar infusion complexity — the monoclonal...0 Comentários 0 Compartilhamentos 148 Visualizações 0 Anterior
-
Kidney Cancer Diagnostics Market – Precision Oncology Tools, Early Detection Technologies & Clinical Accuracy"Executive Summary Kidney Cancer Diagnostics Market: Growth Trends and Share Breakdown CAGR Value Data Bridge Market Research analyzes that the kidney cancer diagnostics market is expected to reach a value of USD 16,862.32 million by 2030, at a CAGR of 6.4% during the forecast period. The key highlights of this Kidney Cancer Diagnostics Market report are key market dynamics, the current...0 Comentários 0 Compartilhamentos 905 Visualizações 0 Anterior
-
Merkel Cell Carcinoma Treatment Market: Immune Checkpoint Inhibitor (ICI) Advancements, Combination Therapy Pipelines, and Precision Oncology Strategies"Latest Insights on Executive Summary Merkel Cell Carcinoma Treatment Market Share and Size Data Bridge Market Research analyses a growth rate in the merkel cell carcinoma treatment market in the forecast period 2022-2029. The expected CAGR of merkel cell carcinoma treatment market is tend to be around 3.87% in the mentioned forecast period. The market was valued at USD 3.24 billion in 2021,...0 Comentários 0 Compartilhamentos 928 Visualizações 0 Anterior
-
Myeloproliferative Disorder Treatment Market Set for Strong Growth as Precision Oncology AdvancesThe global Myeloproliferative Disorder Treatment Market is witnessing substantial growth as advances in precision medicine, targeted therapies, and molecular diagnostics transform the treatment landscape for rare hematologic disorders. Myeloproliferative disorders (MPDs), also known as myeloproliferative neoplasms (MPNs), are a group of chronic blood cancers characterized by the excessive...0 Comentários 0 Compartilhamentos 115 Visualizações 0 Anterior
-
Myxoid Round Cell Liposarcoma (MRCLS) Drug Market – Precision Oncology Therapies, Rare Cancer Research & Clinical Pipeline"Global Executive Summary Myxoid Round Cell Liposarcoma (MRCLS) Drug Market: Size, Share, and Forecast CAGR Value The Global Myxoid Round Cell Liposarcoma (MRCLS) Drug Market size was valued at USD 10.61 billion in 2024 and is expected to reach USD 14.3 billion by 2032, at a CAGR of 3.81% during the forecast period While preparing the first class Myxoid Round Cell Liposarcoma (MRCLS) Drug...0 Comentários 0 Compartilhamentos 638 Visualizações 0 Anterior
-
Adrenal Cancer Diagnostics Market Size, Share and Trends Forecast to 2030According to the latest report published by Data Bridge Market Research, the Adrenal Cancer Diagnostics Market Data Bridge Market Research analyses that the adrenal cancer diagnostics market which was USD 130 billion in 2022, is expected to reach USD 207.20 billion by 2030, at a CAGR of 6% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
-
Asia-Pacific Radiotherapy Market Size and Revenue Forecast to 2032According to the latest report published by Data Bridge Market Research, the Asia-Pacific Radiotherapy Market The Asia-Pacific radiotherapy market size was valued at USD 1.06 billion in 2024 and is expected to reach USD 2.40 billion by 2032, at a CAGR of 11.2% during the forecast period This world-wide Asia-Pacific Radiotherapy Market report is...0 Comentários 0 Compartilhamentos 905 Visualizações 0 Anterior
-
Brigatinib API Market Growing at 8.1% CAGR Through 2034 GloballyAccording to a new report from Intel Market Research, the global Brigatinib API market was valued at USD 42.5 million in 2025 and is projected to reach USD 89.7 million by 2034, growing at a robust CAGR of 8.1% during the forecast period (2026–2034). This growth is propelled by the increasing global incidence of non-small cell lung cancer, particularly ALK-positive cases among...0 Comentários 0 Compartilhamentos 550 Visualizações 0 Anterior
-
Cancer/Tumor Profiling Market Size Projected to Reach USD 23.4 Billion by 2032“According to a new report published by Introspective Market Research, Cancer/Tumor Profiling Market by Technology, Cancer Type, and Application, The Global Cancer/Tumor Profiling Market Size Was Valued at USD 11.08 Billion in 2024 and is Projected to Reach USD 23.4 Billion by 2032, Growing at a CAGR of 9.8%.” Cancer/Tumor Profiling refers to the comprehensive molecular examination...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
-
Crizotinib Drugs Market Growing at 6.7% CAGR Through 2034According to a new report from Intel Market Research, the global Crizotinib Drugs market was valued at USD 582.4 million in 2025 and is projected to reach USD 1,043.7 million by 2034, growing at a CAGR of 6.7% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of lung cancer, increasing adoption of molecular diagnostic testing for genetic...0 Comentários 0 Compartilhamentos 520 Visualizações 0 Anterior
-
Europe Radiotherapy Market, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032According to the latest report published by Data Bridge Market Research, the Europe Radiotherapy Market The Europe radiotherapy market size was valued at USD 2.41 billion in 2024 and is expected to reach USD 4.89 billion by 2032, at a CAGR of 9.7% during the forecast period Getting thoughtful about competitive landscape is another...0 Comentários 0 Compartilhamentos 669 Visualizações 0 Anterior
-
Global Cabozantinib Drug Market Growing at 7.5% CAGR Through 2034According to a new report from Intel Market Research, the global Cabozantinib Drug market was valued at USD 2.12 billion in 2025 and is projected to reach USD 4.01 billion by 2034, growing at a robust CAGR of 7.5% during the forecast period (2026–2034). This growth is propelled by the escalating global burden of cancer, particularly renal and liver cancers, alongside expanding clinical...0 Comentários 0 Compartilhamentos 357 Visualizações 0 Anterior
-
Global Multi-target MET TKIs Market Growing at 7.6% CAGR Through 2034According to a new report from Intel Market Research, the global Multi-target MET TKIs market was valued at USD 1.52 billion in 2025 and is projected to reach USD 3.18 billion by 2034, growing at a CAGR of 7.6% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of non-small cell lung cancer and medullary thyroid cancer, precision oncology...0 Comentários 0 Compartilhamentos 426 Visualizações 0 Anterior
-
Next Generation Cancer Diagnostics Market Size, Share and Trends Forecast to 2029According to the latest report published by Data Bridge Market Research, the Next Generation Cancer Diagnostics Market Data Bridge Market Research analyses a growth rate in the global next generation cancer diagnostics market in the forecast period 2022-2029. The expected CAGR of global next generation cancer diagnostics market is tend to be around 18.1% in the mentioned forecast...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
Precision Oncology Market Dynamics: Opportunities, Challenges, and Emerging Trends 2030Global Precision Oncology Market Outlook: Personalized Cancer Care Driving a USD 190 Billion Opportunity by 2030 The global Precision Oncology Market is undergoing a transformational phase as cancer treatment shifts from conventional protocols toward personalized, molecularly guided therapies. Valued at USD 98.36 billion in 2023, the market is projected to expand at...0 Comentários 0 Compartilhamentos 684 Visualizações 0 Anterior
-
TKIs for Breast Cancer Market Growing at 7.3% CAGR Through 2034According to a new report from Intel Market Research, the global TKIs for Breast Cancer market was valued at USD 1.82 billion in 2025 and is projected to reach USD 3.74 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2025–2034). This growth is propelled by the rising global incidence of breast cancer, growing adoption of precision oncology, and increasing regulatory...0 Comentários 0 Compartilhamentos 458 Visualizações 0 Anterior
Páginas impulsionada
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Greek